Easton Pharmaceuticals, Inc. (EAPH)

[rcaptain]

Own nothing?

TORONTO, ON--(Marketwired - Dec 11, 2013) - Easton Pharmaceuticals (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic healthcare products provides update towards its 2 main initiatives, its minority ownership interest for its early stage cancer drug "Xilive" and on its Mexican government regulatory filing For Its "Viorra" product.